Engineering oligomeric protein self-assembly is an attractive approach to fabricate nanostructures with well-defined geometries, stoichiometry and functions. The homodecamer Brucella Lumazine Synthase (BLS) is a highly stable and immunogenic protein nanoparticle (PNP). Here, we engineered the BLS protein scaffold to display two functions in spatially opposite regions of its structure yielding a Janus-like
Introduction
Self-assembly of biological macromolecules is a key aspect of life. Nucleic acids, lipids and proteins organize into supramolecular arrangements that contribute to the existence of larger structures such as genomes, membranes, cytoskeletons and tissues. Recently, molecular biology knowledge is being applied to obtain bottom-up nanofabrication strategies. DNA nanotechnology, and in particular the DNA origami strategy, has been developed intensely in recent years. In spite of the incredible versatility of DNA self-assembly, the structures formed by nucleic acids tend to be mechanically exible. Obtaining rigid nanostructures requires a careful design of cross-linked hybridization between key parts of the DNA structures. In fact, in nature, rigid biological structures are abundant in proteins. In comparison to nucleic acids, engineering and controlling protein self-assembly is considerably more complex, but holds the potential to generate more rigid and larger structures.
Proteins are highly versatile and present diverse selforganized arrangements. Protein oligomerization depends on the primary peptide sequence as well as external conditions such as pH, temperature, ionic strength and the presence of ligands. The quaternary structure is intimately related to protein functions with a huge diversity in nature. An analysis of the quaternary arrangements of the Protein Data Bank (PDB) entries (https://www.rcsb.org/) classied by the OLIGAMI database 1 reveals that approximately 47% of the catalogued proteins are monomeric and that most of the remaining form low copy number oligomers, mainly dimers (30.9%), trimers (4.6%), tetramers (8.7%) and hexamers (2.9%). In some special cases proteins form bigger complexes of, for example, 10, 12, 24 or 60 subunits. Interestingly, most of the latter structures are homopolymeric and present a high degree of symmetry.
Protein nanoparticles (PNPs) are a special subset of supramolecular protein assemblies. The PNP hallmark is a symmetric, either oligomeric or multimeric repetitive structure, sometimes conferring enhanced stability (e.g. chemical, mechanical or thermal)
2,3 and high immunogenicity. 4 Most of these particles derive from viral scaffold proteins such as viruslike proteins (VLPs), but some non-viral proteins, such as ferritins or small heat shock proteins, also belong to this particular protein class. 5, 6 In some cases, these arrangements form molecular cages able to entrap, for example, small molecules, nucleic acids 7 or multiple proteins 8 within their structure. These characteristics make PNPs very attractive models for bioand nanotechnological developments. By combining protein engineering and chemical manipulation of PNPs, it has been possible to develop novel systems with potential applications in a wide range of elds including vaccine platforms, 5,9 nanomedicine, 10 cargo delivery 11 and nanomaterials.
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The oligomeric state of polypeptides can be altered by manipulating either the external physicochemical conditions, its primary sequence or by producing chemical modications to the scaffold. Engineering protein modules to control molecular selfassembly is a current new challenging and technologically relevant nanofabrication approach. 12, 13 Mutations may be predicted in a target sequence in order to produce a desired effect in an oligomer. Due to the complex nature of the protomer-protomer interaction networks and their difficulty to be accurately predicted, this strategy is particularly well suited for protein ensembles for which their molecular structure is available.
The lumazine synthase (LS, EC 2.5.1.78) enzyme, also known as RibH, belongs to the riboavin biosynthetic pathway found in plants and microorganisms.
14 The LS tertiary structure is highly conserved across taxa, even in very distant primary sequences. Strikingly, very subtle changes in the tertiary structure give rise to radically different quaternary assemblies (Fig. S1 †) : the Type-I LS or RibH/RibH1 group is composed of pentamers and icosahedrons, while the Type-II LS or RibH2 group encompasses only decamers. 15, 16 In all known LS variants, pentamers act always as the basic building blocks of these molecules. Interestingly, the icosahedral Type-I LSs have been extensively used as a model of protein cages for multiple purposes, recently reviewed by Azuma et al.
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The Brucella spp. Lumazine Synthase (BLS) is a homodecamer (Type-II LS) formed by the head-to head association of two homopentamers. 15, 18 BLS plays a key role in the Brucella infectious process, 19 shows high thermal and chemical stability 20 and elicits a strong immunogenic response in different animal models. [21] [22] [23] [24] [25] [26] [27] Its disordered N-termini (rst 8-10 residues of all chains) allow to genetically fuse polypeptides without affecting its structural properties, giving rise to chimeric constructs. BLS has been successfully used as a structural scaffold for vaccine design displaying a multiple variety of epitopes, [28] [29] [30] [31] ranging from linear peptides to protein domains and to entire proteins.
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Two strategies have been previously applied to link two different functions into the same BLS particle. One of them consists of the chemical dissociation of two different homodecameric chimeras of BLS into monomers using a chaotropic agent (for example guanidinium chloride), followed by a mixture and re-association of the monomers by dialysis. 28 The second strategy is based on the genetic fusion of a set of leucine zipper peptide adaptors (leu1 and leu2), one to the BLS Ntermini and the other to the proteins of interest. 34 Then, by mixing leu1-BLS with the two target proteins each fused to leu2, the leucine zippers link both target proteins to BLS. In both cases, the target proteins are stochastically distributed within the scaffold, obtaining a heterogeneous population of heterodecamers.
The next step in tailoring functions of PNPs consists of organizing two or more functional moieties in exact spatial congurations within the same particle. Here, we demonstrate a redesign of the BLS into a Janus-like nanoparticle 35 by generating a decameric structure built from two different pentamers. Based on structural analyses and rational design, we engineered the BLS pentamer-pentamer interface in order to (i) disrupt major interactions between homopentamers and (ii) enable the interaction between heteropentamers. Finally, we performed proof-of-concept functional assays in which we show that this novel protein scaffold presents potential uses in nanobiotechnology such as vaccine design, antigen production and imaging tool development.
Results
In silico analysis of Type-II LS pentamer-pentamer interfaces
As a rst step, we sought to understand the nature of the Type-II LS pentamer-pentamer interaction by analyzing in detail its dimeric equatorial interface. To date, besides BLS, only one Type-II LS crystallographic structure has been solved: RibH2 from the soil bacterium Mesorhizobium loti (MLS) (Fig. 1A) .
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The protein sequence alignment between both LSs shows 61% identical and 77% similar residues. Secondary structural elements and interface contacts between pentamers were identied in both structures and indicated in the primary sequences ( Fig. 1B and Table 1 ). Here, we assume interface contacts when any of the atoms from two residues from different pentamers are at a shorter distance than 4.0Å. The locations of the a-helices and b-sheets in the primary structure are found to be almost identical in both proteins. Table 1 lists all pairs of pentamer-pentamer contacts found in BLS and MLS. As it can be observed, MLS presents additional contacts compared to BLS, two of these interactions (Y120-H121 and R128-E132) being of electrostatic nature. These ndings indicate that the matrix of interactions in the pentamer-pentamer interface is variable among decameric Type-II LS.
In order to evaluate the signicance of the role of each interface interaction, we decided to further characterize the BLS interface. For that aim, we performed thermodynamic calculations in silico by an alanine scanning strategy on all residues identied above as part of the interactions between the two pentamers, called A and B. We used the soware FoldX 36 to calculate Gibbs free energy between pentamers (DG pp ) by nding local minima using a library of rotamers for each mutant (Table S2 †) . The DG pp relative changes of the alanine mutants, taking the wild-type protein (BLS WT ) as the reference, are shown in Fig. 2A . Interestingly, two important sets of interactions between pentamers A and B were identied, exhibiting DG pp reductions of 42% and 90%, which were designated "velcro 1" (H117A and H118A) and "velcro 2" (E124A and F128A/H132A), respectively ( Fig. 2A) . These patches of interactions are highlighted in the BLS structure shown in Fig. 2B in more detail as two insets.
Redesign of the BLS pentamer-pentamer interface
In order to guide the self-assembly of BLS towards the formation of a Janus-like nanoparticle we decided (i) to disrupt the BLS homodecamer assembly by the mutagenesis of some residues at the pentamer-pentamer interface and (ii) to Arrows and cylinders represent a-helices and ß-sheets, respectively; interacting residues from the pentamer-pentamer interfaces (see Table 1 ) are highlighted.
reconstitute a heterodecameric particle by the association of two different mutant pentameric species. Residues within velcros 1 and 2 were initially contemplated as potential candidates to be mutated in order to disable the pentamer-pentamer association. The alanine substitutions of velcro 2 residues ( Fig. 2A) indicate that this patch of interactions is a major contributor in cementing together the two pentamers. A closer look at velcro 2 in the protein structure also suggests its relevant role for maintaining both pentamers bound together by one hydrophobic (F128-F128) and two electrostatic interactions (E124-H132) per pair of opposing protomers (Fig. 2B) . Hence, we decided to leave velcro 2, including F128, unchanged and focus on modifying the interactions of velcro 1. The rationale behind this decision is that a modication of this key interaction patch may result in a high destabilization of the dimeric interface, probably making it more difficult to reconstitute it with complementary mutations for achieving a stable decamer. The interaction between H117 (from pentamer A) and H118 (from pentamer B), in velcro 1, is mainly due to a p-p stacking between the imidazole moieties from both residues (Fig. 2B ).
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We opted to disrupt this p-p interaction by introducing charged residues at the positions 117 and 118. Taking into account their distances and volumes available from the crystallographic model, we designed two different mutants: H117D/ H118D and H117K/H118K. Due to the electrostatic forces generated by the charged residues, these mutations should generate the desired dual effect. Electrostatic repulsion hinders homopentamer self-dimerization due to charges of the same sign at the interface (pentamer A: H117D/H118D, and pentamer B: H117K/H118K) while heterodimer formation is favored by electrostatic attraction (H117D-H118K and H117K-H118D). Based on the same rationale, we decided to introduce two additional salt-bridges in order to strengthen the interaction between mutant pentamers A and B, while further weakening their self-association. The D127-A131 BLS positions correspond in sequence and space to the R128-D132 salt bridge found at the MLS interface ( Fig. 1 ). Therefore, a set of mutations was formulated (pentamer A: D127R/A131R; pentamer B: D127E/ A131E) to emulate MLS in this respect. Furthermore, the introduction of two positively and two negatively charged residues in each mutant maintains the net charge null, preserving their theoretical isoelectric points similar to BLS WT . In total, four point mutations per monomer were conceived, which we named BLS DR and BLS KE for the introduction of Asp, Arg, Lys and Glu residues, respectively ( Table 2 ). The introduced mutations at the interface are represented for both mutants in Fig. 3 , aer modeling their conformation in FoldX. The BLS DR and BLS KE association in a decameric particle, referred to as BLS DRKE , was also modeled. The mutant side chains were able to form the proposed salt bridges, suggesting that these contacts may indeed exist in BLS DRKE .
Pentameric BLS KE and BLS DR associate to form a stable heterodecamer
Recombinant BLS KE and BLS DR mutants were successfully generated, expressed and puried in high yields (Fig. S2 , † see Materials and methods for details). The quaternary structure of these new proteins was rst characterized by performing size exclusion chromatography (SEC) coupled to static light scattering (SLS) measurements for each mutant separately and mixed together, from which their molecular weight (MW) was determined. Fig. 4A shows the SEC elution proles, indicating the mean MW calculated for each sample. Both BLS DR and BLS KE present higher elution volumes (smaller particles) than BLS WT , and the calculated MWs correspond to pentameric species. In accordance with our design, pre-incubation of an equimolar mix of BLS DR and BLS KE produces a new species in the SEC-SLS experiment that matches the elution volume of BLS WT with a MW of 176 AE 2 kDa, which is in agreement with a decameric structure (Fig. 4A ). The BLS DRKE decameric peak was assayed again by SEC-SLS immediately aer mixing (0 h) and aer 24 h. In both cases, a single decameric peak was detected of approximately the same MW (Fig. 4B ). This rules out the existence of a pentamer-decamer dynamic equilibrium, and allows us to conclude that the BLS DRKE heterodimer assembly is stable under these experimental conditions. Due to the electrostatic nature of the novel pentamer-pentamer interactions introduced in BLS DRKE , we wondered whether ionic strength could alter the heteropentamer dimer stability. Therefore, we pre-incubated BLS DRKE in buffers with different NaCl concentrations ranging from 0 to 2 M, and performed SEC-SLS measurements of the samples using the same buffers. All NaCl concentrations assayed yielded decameric species ( Fig. 4C ) similar to BLS WT , indicating a comparably high stability in both decamers under elevated ionic strength conditions. BLS WT presents a pH-dependent pentamer-pentamer dimer dissociation, with a 50% dissociation at a pH of $5.7 ( Fig. 4D and S3 †). Histidine residues are natural candidates for explaining this phenomenon. Due to the elevated amount of histidine residues participating in pentamer-pentamer contacts (25 from a total of 55 residues involved per decamer) and considering that BLS DRKE has 10 histidine residues replaced, we next evaluated whether the pH dependent stability remained unchanged. The results show that, BLS DRKE exhibits a nearly identical pH dissociation curve compared to BLS WT , with a 50% dissociation at a pH value of $5.7 (Fig. 4D) . Thus, the replaced histidine residues H117 and H118 do not play a signicant role in pentamer-decamer equilibrium driven by pH.
To further verify the interpentameric interaction, we performed a Förster resonance energy transfer (FRET) assay by conjugating donor and acceptor uorophores on each pentamer. A point mutation was introduced at position 123 to replace a lysine residue by a cysteine residue, which was subsequently used to chemically link dyes containing maleimide groups in positions near the interface. According to the structure of BLS, the expected separation distance between donor and acceptor uorophores ranges from 19 to 23Å, being suitable for efficient FRET. The new cysteine mutant variants for BLS DR concentrations, the emission peak corresponding to the acceptor (570 nm) increases while the emission peak corresponding to the donor (520 nm) decreases. A FRET efficiency plot was derived from these values (Fig. 4E) . The presence of a clear FRET effect indicates the close spatial proximity of both pentamers in the BLS DRKE particles. Additionally, the structure and stability of BLS DR , BLS KE and BLS DRKE were assessed by temperature curves measured by circular dichroism (CD). First, we compared the CD spectra of BLS pentameric and decameric variants at room temperature, presenting similar curves with two main negative peaks at 208 and 222 nm, and a positive peak at 190-195 nm (Fig. S5A †) , evidencing a combination of a/b structures with a major ahelical component. These results indicate that the mutations do not introduce signicant changes in the secondary structures of BLS DR , BLS KE or BLS DRKE . Next, in order to interrogate the thermal stability of the BLS variants, their molar ellipticity signal at 222 nm was recorded as a function of temperature. The results show similar unfolding curves for BLS DRKE forming a decameric uorescent complex. Hence, we rst generated, expressed and puried VP8-BLS KE and corroborated by CD, SEC-SLS, and SDS-PAGE analyses that: (i) the secondary and tertiary structures of both domains are not affected when fused into a chimera (Fig. S5B †) , (ii) it is in fact a pentamer in solution, and (iii) it has the capacity to bind to BLS DR giving rise to a particle with a MW corresponding to a decamer (Fig. 6) . Then, we performed two different labelling assays to demonstrate the potential, versatility and specicity of this platform. The rst assay consisted of incubating a monolayer of adhered HeLa cells with VP8-BLS KE and A488 BLS DR , followed by several washing steps and then visualization by confocal microscopy (Fig. 7A ). Cells treated in this way display a clear uorescent signal. Control treatment using BLS KE and A488 BLS DR showed no substantial signal, indicating that the labeling is specic due to the presence of VP8 (Fig. 7A) (Fig. S6 †) . Altogether, these results indicate that the presence of the VP8 domain in the uorescent decamer confers binding specicity to molecules of sialic acid present on the cell surface. We then assayed how the heterodecamer concentration affects the labeling. For that purpose, cell suspensions were incubated with increasing amounts of VP8-BLS KE and A488 BLS DR . This experiment showed that there is a clear dependency of the signal distribution on the amount of VP8-BLS KE and A488 BLS DR used in each treatment, also indicating that the system did not reach its saturation limit in the range tested (Fig. 7B) .
Building a multichromophoric FRET model
FRET is a mechanism of energy transfer based on the dipoledipole interaction that is active between two uorophores in close proximity. Typically, it occurs when the separation distance is below 5-10 nm. Multichromophoric energy transfer plays a key role in natural systems such as light harvesting complexes.
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Fabrication of articial multichromophoric systems is highly challenging, since it requires the organization of uorophores with regular separation distances in a welldened geometry with a precision of just a few nanometers. [39] [40] [41] [42] Our BLS model is a promising platform to achieve this goal taking advantage of protein self-assembly, analogously to natural complexes.
We began to explore the use of the bifunctional BLS PNPs as a synthetic model to study multichromophoric FRET at the single molecule level (smFRET). We labeled positions 123 of the monomers of BLS DR and BLS KE with the Cy3 and Cy5 uores-cent dyes, respectively, as suitable donor and acceptor dyes for smFRET. Individual Cy3 BLS DR and Cy5 BLS KE pentamers were readily detected on a two-color wide-eld epiuorescence microscope in total internal reection illumination mode (TIRF), upon excitation with laser light of 532 and 642 nm, respectively (Fig. S7 †) . Although 10-12% of cross-talk was found in the Cy5 channel when Cy3 BLS DR was excited at 532 nm, this is clearly differentiated from direct signals (Fig. S8 †) . The isolated Cy3 BLS DR and Cy5 BLS KE particles display multiple discrete uo-rescence intensity steps. Approximately 10% of the PNPs showed 5 intensity steps ( Fig. 8A and B) , while the rest of the PNPs displayed 2, 3 or 4 uorescence steps, indicating that the protein complexes were labeled with varying amounts of uorophores. The next step was to assemble the heterodecamer, positioning multiple uorophores in the equatorial part of the molecules (Fig. 8C) . For that aim, equimolar mixtures of labeled pentamers or pentamers alone were pre-incubated at room temperature prior to their deposition onto microscope coverslips. Co-incubation of Cy3 
BLS DR and
Cy5 BLS KE produced uo-rescent particles with signals corresponding to Cy5 BLS KE that could be detected in the Cy5 emission channel when excited with both 532 and 642 nm. These uorescent spots also overlapped with uorescent signals from the Cy3 emission channel under excitation at 532 nm (Fig. S8 †) . These results indicate that FRET indeed occurs within those doubly labeled uorescent PNPs. The two-color emission time traces of the multichromophoric particles present complex anticorrelated signals (Fig. 8D) , revealing a variety of smFRET events probably due to the different number and orientation of active uo-rophores (e.g. caused by chemical bond rotations and protein backbone movements) at each given time within individual particles.
Discussion and conclusions
In the present work we have achieved the engineering of protein self-assembly in order to obtain a Janus-like functional particle scaffold. Our strategy consisted of generating two mutant pentameric variants of the BLS homodecameric protein, introducing charged residues in their pentamer-pentamer interfaces which prevented self-dimerization and simultaneously promoted heterodecamer formation through charge complementation. By this means, a precise control of the BLS multimer spatial conguration was achieved. The variants of BLS pentamers may be fused to other proteins or to chemical groups that could be employed to build novel nano-objects and nanomaterials, creating PNPs that can hold up to ve copies of each function ordered in both sides of the scaffold. The pentavalent display of certain molecules such as uorophores, enzymes or binding domains, with high local concentration, may enable for example, enhanced uorescent signals, higher enzymatic reaction speeds and increased binding avidities. Moreover, following this scheme it is now possible to develop a pentameric library with different kinds of functions, which may be combined as desired in the same PNP. The addition of each new function could increase the combinatorial, and thus the possible technological applications.
It is important to note that these new pentameric proteins conserve many of the structural properties of BLS WT and bring new characteristics that may be interesting for nanotechnological developments. When BLS KE and BLS DR are assembled into a decameric particle, it shows high temperature stability, and quaternary structure stability in a wide range of ionic strengths and at pH values over 5.5. Decameric BLS DRKE also conserves the intrinsic immunogenicity of BLS WT , which makes this system useful for vaccine engineering. In this sense, the BLS scaffold has been demonstrated to be successful for displaying foreign antigens, which has led to the patenting of this technology. 43, 44 In this work, we have expanded its capabilities, bringing the possibility to display two types of antigens (i.e. for multivalent vaccines) or an antigen and an immunomodulator (i.e. for immunomodulatory antigen delivery systems) within the same particle. On the other hand, the cellular labeling assays performed in this work indicate that the engineered versions of BLS could eventually be used as diagnostic or therapeutic tools. DNA origami technology has recently become a powerful nanofabrication tool. However, achieving 3D or rigid structures using DNA is challenging due to the intrinsic exibility of DNA. Proteins, on the other hand, can present naturally rigid and thermally stable tertiary and quaternary structures. Here, we have demonstrated that BLS and its variants can be used as versatile nanometric scaffolds to organize various molecular entities in space. In addition to the multivalent uorescent labeling, we have used bifunctional PNPs to construct a multichromophoric energy transfer system, a highly challenging task as it requires the organization of multiple molecules at separation distances of 1-3 nm. Model systems in which the location and distances between chromophores are well controlled at this scale are powerful tools to understand in deeper detail photosynthetic processes and/or to engineer articial photosynthetic structures.
In summary we have presented a new method for devising asymmetric, bifunctional PNPs with clear potential applications in (bio)nanotechnology. As we gain detailed knowledge of protein structures and interactions, new nanofabrication avenues through biomolecular self-assembly analogous to the one here presented will be opened.
Materials and methods

In silico structural analysis
The crystallographic structures of BLS and MLS (PDB entries 1XN1 and 2OBX, respectively) were analyzed to identify the residues involved in the pentamer-pentamer interactions.
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Interatomic distances between all residue-atoms from the different pentamers were measured using the web server CoCoMaps (https://www.molnac.unisa.it/BioTools/cocomaps/). Contacts were considered for residue atoms involved in their interactions (i.e. electrostatic, hydrophobic or p-p stacking) at distances shorter than 4.0Å and are detailed in Table 1 .
In silico thermodynamic stability studies and complex formation were carried out using the FoldX program (http:// foldxsuite.crg.eu/). The PDB 1XN1 model was used as a template for all BLS in silico mutations. An alanine scanning was performed in all residues identied in the pentamer dimer interface using CoCoMaps. For each residue, mutations were made in all monomers at the same time. Each mutation was performed 5 times and the contribution to the total interaction energy between pentamers was calculated as the average. The set of selected mutations to simultaneously disrupt the selfinteractions between mutant pentamers and to favor heteropentamer interactions are shown in Table 2 . BLS DR , BLS KE and BLS DRKE mutant decamers were analyzed using FoldX Stability and AnalyzeComplex functions.
Site-directed mutagenesis and VP8-BLS fusion
The pBLS WT plasmid carries the BLS gene (UniProt Q2YKV1) cloned in a pET11a plasmid (Novagen) between NdeI/BamHI sites, and possesses a wild-type interphase and an N-terminal C5S substitution to avoid the use of reducing agents to impair aggregation. All BLS mutant versions were generated by whole plasmid amplication PCR using the Q5 High-Fidelity DNA Polymerase (New England Biolabs), specic primers (Table S1 †) and pET11a derived vectors as templates. Briey, inverted and overlapping forward and reverse primers containing the mutations were used for 14-18 cycles PCRs using methylated plasmids as templates. Then, the reactions were treated with DpnI and transformed into E. coli DH5a cells. Clones were screened and conrmed by Sanger sequencing. By this means we generated the pBLS WT , pBLS D , pBLS DR , pBLS K , pBLS KE , pBLS DR-C and pBLS KE-C plasmids, as detailed in Table S1 . † The VP8-BLS fusion construct was achieved rst by PCR amplication of the 18 kDa sialic acid binding domain product from the C486 bovine rotavirus (BRV) VP8 core protein (VP8d), including the pentapeptide linker GSGSG, using Pfx DNA polymerase (Invitrogen), specic primers with homologous ends to the target plasmid and the pVP8-BLS plasmid as templates. The pVP8-BLS plasmid was kindly provided by Dr Patricio Craig.
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Then, the 0.5 kbp VP8d amplicon was used as the primer in a whole plasmid amplication PCR using the Q5 High-Fidelity DNA Polymerase and the pBLS KE plasmid as templates. Similarly as explained above, the reaction was treated with DpnI and transformed into E. coli DH5a cells. Clones carrying the 1.0 kbp fragment from the VP8d-linker fused to the BLS KE N-terminus at residue number 7 were screened using PCR and conrmed by Sanger sequencing, resulting in the pVP8-BLS KE plasmid (Table S1 †) .
For full details on the protein sequences used in this work see section "BLS protein sequences" in the ESI. †
Protein expression and purication
Vectors coding for BLS WT 
Static light scattering measurements
The molecular weight (MW) of proteins in solution was determined using a Precision Detectors PD2010 light scattering instrument connected in tandem to a Gilson high-performance liquid chromatography (HPLC) system, a Waters 486 UV detector and a LKB 2142 differential refractometer. BLS proteins (0.2-1 mg ml À1 ) were analyzed in a Superdex 200 HR-10/30 column (24 ml; GE Healthcare Life Sciences) and using an isocratic elution buffer (50 mM Tris-HCl pH 8.0, 0.25 M NaCl). The effect of ionic strength on dimerization was evaluated by only varying the total salt concentration (0-2 M NaCl). The effect of pH on dimerization was studied using a citrate-phosphate buffer (pH 4.0-8.0, 0.25 M NaCl). Scattered light at 90 , UV absorbance at 280 nm, and the refractive index (RI) signals were measured. The data were analyzed with Discovery32 soware (Precision Detectors). The MW for each sample was calculated by using the SLS and RI signals, with bovine serum albumin (BSA) as a calibration standard (66.5 kDa).
Far-UV circular dichroism
Circular dichroism (CD) spectra were monitored in the far-UV region using a J810 spectropolarimeter (Jasco). Then, the unbound dyes were removed using a G25 minitrap column (GE Healthcare). Finally, the labeled proteins were concentrated to $50 mg ml À1 stocks and stored at À80 C for further use. A488 BLS DR in PBS, pH 8 and 600 ml total volume was mixed with increasing concentrations (0-600 nM) of A555 BLS KE . The excitation and emission spectra were measured using a Jasco FP-500 spectrouorometer. The 520 and 570 nm signals were determined from the emission spectra of the protein mixture by exciting the donor at 470 nm. The emission at 570 nm was then determined by exciting the acceptor at 540 nm. The raw uo-rescence emission signals were corrected for background and averaged over three experiments at each specic condition. FRET efficiency was calculated using the following equation:
where E is the FRET efficiency, FDA is the uorescence of the donor in the presence of the acceptor, FD is the uorescence of the donor in the absence of the acceptor and R 0 is the Förster radius (70Å 
Enzyme-linked immunosorbent assay (ELISA)
Standard ELISA procedures were followed to measure antibody production against the BLS protein variants in mice sera. Briey, Nunc Maxisorp plate wells were coated or not (for nonspecic signal) with 50 ml of BLS proteins (0.2 mg per well), and then blocked with 1% skim milk in PBS. Then, serial dilutions for each serum were incubated, washed and treated with peroxidase-conjugated polyclonal antibodies against mice IgG (Sigma, St. Louis, MO). The serum reactivity was developed by adding 50 ml of 2 mg ml À1 o-phenylenediamine (OPD) and 0.03% H 2 O 2 in 0.1 M citrate phosphate buffer. The reaction was
stopped with 50 ml of 4 N H 2 SO 4 and the absorbance at 492 nm was recorded using a plate reader (SLT Lab Instruments washed twice with PBS, centrifuged at 400 g and resuspended in 200 ml PBS. Finally, cellular bound uorescence was quantied by ow cytometry using a uorescence-activated cell sorting system (FACScan cytometer, BD Biosciences). Data were analyzed with the CellQuest soware (BD Immunocytometry Systems) and FlowJo v7.6.2 soware (https:// www.owjo.com/).
Single-molecule FRET (smFRET)
Samples were prepared in Lab-Tek II chambered coverglasses (Nunc), previously treated with KOH 1 M, a 0.48% (v/v) aqueous solution of Poly(diallyldimethylammonium) chloride (Sigma Aldrich) and blocked BSA 1%. Cy3 BLS DR and Cy5 BLS KE PBS buffer solutions were pre-incubated for 30 min at room temperature, separated or in equimolar mixtures, at 0.5 mM for each labeled pentamer. Then, coverglasses were treated for 1 s with each protein solution and washed 10 times with PBS buffer. Each sample was incubated with imaging buffer (to stabilize blinking and avoid photobleaching) containing 50 mM Tris pH 8, 10 mM NaCl, 10% (w/v) glucose, 100 mM mercaptoethylamine, 1 mg ml À1 glucose oxidase, 0.5 mg ml À1 catalase and 2 mM Trolox (Acros Organics, Fisher Scientic). smFRET was carried out using a microscope home-built around an Olympus IX-73 body, operating in wide-eld epiuorescence mode. Two color images were acquired with an oil immersion objective Olympus PlanApo 60x NA 1.42. Total internal reection illumination mode (TIRF) was enabled by moving a linear stage (Thorlabs) so that the focus of the lasers translated laterally within the back focal plane of the objective. Fluorescence emission from Cy3 and Cy5 was separated with a dichroic mirror (Chroma ZT647rdc), ltered with bandpass emission lters (Semrock 582/75 BrightLine HC and Chroma ET700/75m) and imaged onto adjacent areas of the EMCCD camera operated at À50 C (Andor iXon3 897). The camera and the lasers were controlled with custom soware previously described. 46 A 642 nm 1.5 W laser (MPB Communications, 2RU/ VFL/P/1500/642) and a 532 nm 1.5 W laser (Laser Quantum, ventus 532) were used for uorescence excitation of Cy5 and Cy3, respectively. The lasers were combined with dichroic mirrors (Semrock LM01-427, LM01-552 and Di03-R405/488/532/ 635-t1) and then focused to the back focal plane of the objective. Further blocking of the illumination lasers was performed with a multi-edge notch lter (Semrock NF03-05/488/532/635E). Laser power densities used during acquisition were 555 W cm À2 and 610 W cm À2 for 532 and 642 nm, respectively. A PreAmp Gain of 5.1 and an EM Gain of 50 were used in the CCD camera. Different regions of 128 Â 128 pixels ($290 mm 2 ) were observed using 100 ms exposure times. Single molecule time traces were achieved aer background subtraction, using a region of interest of 5 Â 5 pixels ($0.44 mm 2 ). Cross-talk was characterized in samples containing either Cy3 or Cy5, and was then used to correct Cy3 and Cy5 traces. Differences between the two channels were corrected by imaging isolated uorescent markers visible on both channels (Life Technologies Tetraspeck 0.1 mm) and then nding the affine transformation that minimizes the distance between the same markers as detected in each detection channel as previously described.
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Statistical analysis
Statistical analysis was performed with the InfoStat 2014 soware (https://www.infostat.com.ar/) and GraphPad Prism version 6.00 soware (https://www.graphpad.com/). One-way ANOVA followed by non-parametric analysis of variance (Kruskal-Wallis) and paired comparisons (Mann-Whitney) were performed.
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